Rivaroxaban or Combo Therapy: A Winner for All Ages? – Medscape

Rivaroxaban or Combo Therapy: A Winner for All Ages?  MedscapeRivaroxaban Monotherapy Benefits Those with Atrial Fibrillation, Stable Coronary Artery Disease  HCPLiveBlood thinner alone may be enough for some older heart patients  McKnight’s Long-Term Care NewsRivaroxaban Monotherapy Effective Across Age Groups in Atrial Fibrillation Patients With Stable CAD:…  Medical Dialogues